After 72 weeks of treatment, participants reported higher rates of histological resolution of steatohepatitis and improvement in liver fibrosis those who received placebo, alongside substantial weight reduction [50, 51]
I finally feel like myself again, and I plan to stay this way.* Ruth W
Ongoing support, regular follow-ups, and realistic expectations are key to achieving the best possible outcomes
No, retatrutide is still investigational and has not yet received FDA approval
This clinical oversight is essential for safety and for ensuring that the medication is working effectively for your specific body type
Key References Burlina S, Dalfra MG, Caprino R, Lapolla A